Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Oncologic safety of sentinel lymph node–based nodal de-escalation in apparent uterine-confined endometrial cancer: a multicenter international cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2023.0006 · 2023 · External reference
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
10.1016/s0140-6736(08)61766-3 · 2009 · External reference
Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: a randomized clinical trial
10.1093/jnci/djn397 · 2008 · External reference
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial)
10.1056/nejmoa1613792 · 2017 · External reference
Detection rate and diagnostic accuracy of sentinel-node biopsy in early-stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)
10.1016/s1470-2045(11)70070-5 · 2011 · External reference
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
10.1016/s1470-2045(25)00167-6 · 2025 · External reference
Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer: combined analysis of the PORTEC cohorts
10.1158/1078-0432.ccr-15-2878 · 2016 · External reference
Substantial lymphovascular space invasion is a significant risk factor for recurrence in endometrial cancer: a pooled analysis of PORTEC trials
10.1016/j.ejca.2015.06.008 · 2015 · External reference
The risk of recurrence in endometrial cancer patients with low-volume metastasis in the sentinel lymph nodes: a retrospective multi-institutional study
10.3390/cancers15072052 · 2023 · External reference
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes
10.1016/j.ygyno.2012.02.021 · 2012 · External reference
Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer
10.1136/ijgc-2023-005157 · 2024 · External reference
Lymph node staging update in the American Joint Committee on Cancer 8th edition cancer staging manual
10.1016/j.ygyno.2018.02.021 · 2018 · External reference
The impact of substantial lymphovascular space invasion on sentinel lymph node status and recurrence in endometrial cancer patients (SLYM-EC study)
10.1016/j.ejso.2024.108731 · 2024 · External reference
SLYMEC II study: overall survival analysis of the impact of lymphovascular space invasion in apparent early-stage endometrioid endometrial cancer
10.1016/j.ejso.2025.109750 · 2025 · External reference
Lymphadenectomy for high-grade endometrial cancer: does it impact lymph node recurrence
10.1016/j.ejso.2021.11.009 · 2022 · External reference
Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis
10.3802/jgo.2023.34.e79 · 2023 · External reference
The impact on survival of two different staging strategies in apparent early-stage endometrial cancer
10.1016/j.ygyno.2017.09.033 · 2017 · External reference
Multicenter study comparing oncologic outcomes after sentinel lymph node algorithm versus comprehensive lymphadenectomy in serous and clear cell endometrial carcinoma
10.1016/j.ygyno.2019.11.002 · 2020 · External reference
Sentinel lymph node algorithm versus comprehensive lymphadenectomy in deeply invasive endometrioid endometrial carcinoma
10.1016/j.ygyno.2018.08.022 · 2018 · External reference
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: 5-year oncologic outcomes
10.1016/j.ejso.2024.108018 · 2024 · External reference
The added value of sentinel node mapping in endometrial cancer
10.1016/j.ygyno.2020.04.687 · 2020 · External reference
Sentinel node mapping versus lymphadenectomy in endometrial cancer: a systematic review and meta-analysis
10.1016/j.ygyno.2019.03.254 · 2019 · External reference
Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer
10.1016/j.ygyno.2017.01.013 · 2017 · External reference
Prognostic significance of histological grade in low-risk endometrial cancer
10.7150/ijms.77152 · 2022 · External reference
Risk factors for recurrence in low-risk endometrial cancer
10.1159/000488112 · 2018 · External reference
Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer
10.1200/jco.20.00549 · 2020 · External reference
Prognostic significance of molecular classification in high-risk endometrial cancer undergoing sentinel lymph node mapping
10.1016/j.ejso.2025.110385 · 2025 · External reference
Prognostic impact of low-volume nodal metastases in endometrial cancer: a systematic review of molecular subtypes
10.3389/fmed.2025.1671823 · 2025 · External reference
SENECA study: staging endometrial cancer based on molecular classification
10.1136/ijgc-2024-005030 · 2024 · External reference
Added prognostic value of sentinel lymph node mapping in endometrial cancer according to molecular subgroups
10.1016/j.ygyno.2024.12.014 · 2025 · External reference
Oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT trial)
10.1136/ijgc-2020-001698 · 2020 · External reference
Sentinel lymph node mapping versus systematic lymphadenectomy in endometrial cancer (ALICE trial)
10.1136/ijgc-2022-003378 · 2022 · External reference
Sentinel node biopsy versus no retroperitoneal node dissection in apparent early-stage endometrial cancer (ENDO-3)
10.1136/ijgc-2021-003029 · 2021 · External reference
Comparison of sentinel lymph node mapping with comprehensive lymphadenectomy in p53-mutated endometrial cancer: a prospective, multi-center, non-inferiority, open-label, de-escalation, randomized, controlled trial (Study Protocol - SENTIMETREP53)
10.1016/j.ijgc.2026.104547 · 2026 · External reference
Machine learning endometrial cancer risk prediction model integrating ESMO guidelines with tumor immune features
10.1136/ijgc-2023-004671 · 2023 · External reference
Training, validating, and testing machine learning models for endometrial cancer recurrence
10.1200/po-24-00859 · 2025 · External reference